Keywords: AstraZeneca, Pfizer, Nexium, Over-the-counter rights, OTC, Earnings guidance

AstraZeneca to get $250 million-plus from OTC Nexium deal with Pfizer

Article | 15 August 2012

Print This

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says it has entered into an agreement with Pfizer (NYSE: PFE), the world’ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in